Zdrowie i gospodarka · 16/11/1999

FDA Revokes Patient Labeling Requirement for Progestational Drug Products

The US Food and Drug Administration (FDA) is eliminating the requirement for patient labeling on progestational drugs, citing a lack of evidence for increased birth defect risk and the complexity of these medications' uses.